PL355171A1 - Etery 0-demetylowenlafaksyny - Google Patents

Etery 0-demetylowenlafaksyny

Info

Publication number
PL355171A1
PL355171A1 PL00355171A PL35517100A PL355171A1 PL 355171 A1 PL355171 A1 PL 355171A1 PL 00355171 A PL00355171 A PL 00355171A PL 35517100 A PL35517100 A PL 35517100A PL 355171 A1 PL355171 A1 PL 355171A1
Authority
PL
Poland
Prior art keywords
ethers
desmethyl venlafaxine
desmethyl
venlafaxine
Prior art date
Application number
PL00355171A
Other languages
English (en)
Other versions
PL202846B1 (pl
Inventor
John Patrick Yardley
Magid Abdel-Megid Abou-Gharbia
John William Ullrich
Original Assignee
Wyeth
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth filed Critical Wyeth
Publication of PL355171A1 publication Critical patent/PL355171A1/pl
Publication of PL202846B1 publication Critical patent/PL202846B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL355171A 1999-11-24 2000-11-21 Etery O-desmetylowenlafaksyny, sposób ich wytwarzania oraz kompozycja farmaceutyczna zawierająca te związki PL202846B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US44826899A 1999-11-24 1999-11-24

Publications (2)

Publication Number Publication Date
PL355171A1 true PL355171A1 (pl) 2004-04-05
PL202846B1 PL202846B1 (pl) 2009-07-31

Family

ID=23779642

Family Applications (1)

Application Number Title Priority Date Filing Date
PL355171A PL202846B1 (pl) 1999-11-24 2000-11-21 Etery O-desmetylowenlafaksyny, sposób ich wytwarzania oraz kompozycja farmaceutyczna zawierająca te związki

Country Status (24)

Country Link
EP (1) EP1232141B1 (pl)
JP (1) JP2003514889A (pl)
KR (1) KR100843991B1 (pl)
CN (2) CN1198793C (pl)
AR (1) AR024498A1 (pl)
AT (1) ATE278659T1 (pl)
AU (1) AU767835B2 (pl)
BR (1) BR0015795A (pl)
CA (1) CA2391288A1 (pl)
CZ (1) CZ20021816A3 (pl)
DE (1) DE60014693T2 (pl)
DK (1) DK1232141T3 (pl)
ES (1) ES2228636T3 (pl)
HU (1) HUP0203594A2 (pl)
IL (2) IL149531A0 (pl)
MX (1) MXPA02005174A (pl)
NO (1) NO20022446L (pl)
NZ (1) NZ519130A (pl)
PL (1) PL202846B1 (pl)
PT (1) PT1232141E (pl)
SI (1) SI1232141T1 (pl)
TW (1) TWI268919B (pl)
WO (1) WO2001038293A1 (pl)
ZA (1) ZA200204986B (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6602911B2 (en) * 2001-11-05 2003-08-05 Cypress Bioscience, Inc. Methods of treating fibromyalgia
KR101477154B1 (ko) * 2010-10-01 2014-12-29 산동 루예 파마슈티칼 컴파니 리미티드 4-[2-디메틸아미노-1-(1-하이드록시사이클로헥실)에틸]페닐 4-메틸벤조에이트 하이드로클로라이드의 다형체, 이의 제조 방법 및 이의 용도
CN103319373B (zh) * 2012-03-23 2017-09-19 浙江九洲药业股份有限公司 1‑[2‑氨基‑1‑(4‑苄氧基苯基)乙基]环己烷醇的制备方法及相关中间体

Also Published As

Publication number Publication date
CN1198793C (zh) 2005-04-27
DE60014693T2 (de) 2005-03-10
EP1232141B1 (en) 2004-10-06
NZ519130A (en) 2003-09-26
AU1783301A (en) 2001-06-04
CA2391288A1 (en) 2001-05-31
MXPA02005174A (es) 2002-11-07
CN1399626A (zh) 2003-02-26
AR024498A1 (es) 2002-10-02
DK1232141T3 (da) 2004-11-29
IL149531A (en) 2008-12-29
PL202846B1 (pl) 2009-07-31
SI1232141T1 (en) 2004-12-31
HUP0203594A2 (en) 2003-02-28
NO20022446D0 (no) 2002-05-23
CN1636559A (zh) 2005-07-13
JP2003514889A (ja) 2003-04-22
CZ20021816A3 (cs) 2002-08-14
BR0015795A (pt) 2002-07-23
PT1232141E (pt) 2004-12-31
HK1045835A1 (en) 2002-12-13
WO2001038293A1 (en) 2001-05-31
ES2228636T3 (es) 2005-04-16
IL149531A0 (en) 2002-11-10
NO20022446L (no) 2002-05-23
DE60014693D1 (en) 2004-11-11
AU767835B2 (en) 2003-11-27
ATE278659T1 (de) 2004-10-15
ZA200204986B (en) 2003-09-27
KR20030058931A (ko) 2003-07-07
EP1232141A1 (en) 2002-08-21
KR100843991B1 (ko) 2008-07-07
TWI268919B (en) 2006-12-21

Similar Documents

Publication Publication Date Title
HUP0105096A3 (en) Preparation of iodixanol
HUP0402269A3 (en) Methods for preparing o-desmethylvenlafaxine
AU2002364517A1 (en) Tramadol analogs and uses thereof
GB9912356D0 (en) Generation of microfoam
AU5738700A (en) Enantiomers of o-desmethyl venlafaxine
EP1419135A4 (en) PROCESS FOR THE PREPARATION OF TOLTERODINE
IL154220A0 (en) Process for the preparation of substituted phenylacetonitriles
IL144470A0 (en) Calcilytic compounds
HUP0202167A3 (en) Calcilytic compounds
IL149531A0 (en) Ethers of o-desmethyl venlafaxine
AU2002322326A1 (en) Tolterodine metabolites
IL136957A0 (en) Purification of tramadol
AU2629599A (en) Purification of tramadol
GB0127100D0 (en) Elastic support band
TW512678U (en) Improved structure of integrally-formed bra
AU3464P (en) STRGRA Magnolia grandiflora
AU4271P (en) MGTIG Magnolia grandiflora
AU4189P (en) TMGH Magnolia grandiflora
AU3340P (en) JURmag2 Magnolia xsoulangeana
PL332464A1 (en) Seeding assembly
TW535509U (en) Improved structure of bra
TW533817U (en) Assembly structure of elastic strip of chair
AU2003200051A1 (en) Respiratory Mask Assembly
TW427143U (en) Assembly structure for frame body of display frame
TW484451U (en) Improvement of connecting structure for comprehenssive assembly pieces

Legal Events

Date Code Title Description
LAPS Decisions on the lapse of the protection rights

Effective date: 20091121